183 related articles for article (PubMed ID: 35443837)
1. The Association Between Low T3 Syndrome and Survival in Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Study.
Pan Q; Jian Y; Zhang Y; Zhang W; Chen Z; Yang Y; Liu A; Wang G
Technol Cancer Res Treat; 2022; 21():15330338221094422. PubMed ID: 35443837
[No Abstract] [Full Text] [Related]
2. [The impact of low T3 syndrome on the prognosis of patients with newly diagnosed multiple myeloma].
Zhang J; Zhang LN; Xia Y; Jin YY; Shen XX; Chen LJ
Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):216-221. PubMed ID: 37356983
[No Abstract] [Full Text] [Related]
3. Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma.
Gao R; Liang JH; Wang L; Zhu HY; Wu W; Wu JZ; Xia Y; Cao L; Fan L; Yang T; Li JY; Xu W
Br J Haematol; 2017 Apr; 177(1):95-105. PubMed ID: 28146267
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic Value of CD56 Expression in Newly Diagnosed Multiple Myeloma Patients and Its Related Factors].
Wang XX; Zhang LL; Wang T; Hou JX; Wang ZT; Qin H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):777-782. PubMed ID: 37356939
[TBL] [Abstract][Full Text] [Related]
5. Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia.
Gao R; Chen RZ; Xia Y; Liang JH; Wang L; Zhu HY; Zhu Wu J; Fan L; Li JY; Yang T; Xu W
Int J Cancer; 2018 Aug; 143(3):466-477. PubMed ID: 29457831
[TBL] [Abstract][Full Text] [Related]
6. Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma.
Xue LG; Shen HR; Gao R; Du KX; Xing TY; Wang WT; Wang L; Li JY; Liang JH; Xu W
Ann Hematol; 2023 Apr; 102(4):851-862. PubMed ID: 36735075
[TBL] [Abstract][Full Text] [Related]
7. Low T3 syndrome as a predictor of poor prognosis in peripheral T-cell lymphomas.
Li W; Gao R; Wang W; Tang J; Yin H; Wu J; Liang J; Li Y; Wang L; Li J; Shen H; Xu W
Clin Transl Oncol; 2024 Mar; 26(3):613-622. PubMed ID: 37460749
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic Value of A New Risk Stratification Model (R2-ISS) in Newly Diagnosed Multiple Myeloma].
Wang Y; Yue LL; Zeng PY; Wu CY; Han Y; Song Y; Jin QQ; Jiang HY; Chai Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1779-1784. PubMed ID: 36476903
[TBL] [Abstract][Full Text] [Related]
9. [The Influence of CONUT Score on the Prognosis of Patients with Multiple Myeloma].
Li YQ; Wang Y; Song Y; Han Y; Li JJ; Yue LL; Zeng PY; Wu CY; Chai Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):781-786. PubMed ID: 34105472
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between Peripheral Blood PLR with Treg, Th17 in Newly Diagnosed Multiple Myeloma and Its Influence on Prognosis].
Qin N; Feng RT; Wang X; Guo SX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1757-1763. PubMed ID: 38071057
[TBL] [Abstract][Full Text] [Related]
11. Association Between Low T3 Syndrome and Poor Prognosis in Adult Patients With Acute Myocarditis.
Zhao Y; Wang W; Zhang K; Tang YD
Front Endocrinol (Lausanne); 2021; 12():571765. PubMed ID: 33763025
[TBL] [Abstract][Full Text] [Related]
12. Low T3 syndrome is a prognostic marker of poor outcomes in secondary hemophagocytic lymphohistiocytosis.
Yin GL; Huang JY; Tian T; Duan LM; Xu J; Qiu HX
Leuk Lymphoma; 2020 Dec; 61(12):2947-2954. PubMed ID: 32643969
[TBL] [Abstract][Full Text] [Related]
13. High Expression of Phosphorylated Extracellular Signal-Regulated Kinase (ERK1/2) is Associated with Poor Prognosis in Newly Diagnosed Patients with Multiple Myeloma.
Fan L; Hong J; Huang H; Fu D; Wu S; Wang Q; Ye Y; Liu Y
Med Sci Monit; 2017 May; 23():2636-2643. PubMed ID: 28557972
[TBL] [Abstract][Full Text] [Related]
14. [Predictive Value of Pre-treatment Serum Uric Acid Level for Prognosis in Newly Diagnosed Patients with Multiple Myeloma].
Xu SQ; Zhao P; Wang ZH; Deng H; Zhang L; Wei J; Zou XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1216-1223. PubMed ID: 34362505
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Serum Free Light Chain on Renal Function and Prognosis in Patients with Newly Diagnosed Multiple Myeloma].
Chen XD; Luo XF; Zu YP; Ye H; Li LL; Chen QL; Xie WZ; Yang T; Hu JD; Wei LX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1862-1868. PubMed ID: 31839051
[TBL] [Abstract][Full Text] [Related]
16. The role of cystatin C in multiple myeloma.
Zhang J; Jiang Y; Guo D; Liu HY; Hong L; Qi J; Huang H
Int J Lab Hematol; 2022 Feb; 44(1):135-141. PubMed ID: 34549533
[TBL] [Abstract][Full Text] [Related]
17. [Expression of SIL-2R in Patients with Multiple Myeloma and Its Clinical Significance].
Lin P; Lin XR; Liu QL; Zhang XY; Chen GW; Xie RT; Zhang YL; DU XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1797-1802. PubMed ID: 36476906
[TBL] [Abstract][Full Text] [Related]
18. [Impact of low T3 syndrome on adverse cardiovascular events in adult patients with acute viral myocarditis].
Zhao Y; Wang WY; Tian J; Zhang X; Yang M; Chen J; Mu M; Tang YD
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Jun; 47(6):447-451. PubMed ID: 31262128
[No Abstract] [Full Text] [Related]
19. Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies.
Sciacchitano S; De Vitis C; D'Ascanio M; Giovagnoli S; De Dominicis C; Laghi A; Anibaldi P; Petrucca A; Salerno G; Santino I; Amodeo R; Simmaco M; Napoli C; Tafuri A; Di Napoli A; Sacconi A; Salvati V; Ciliberto G; Fanciulli M; Piaggio G; de Latouliere L; Ricci A; Mancini R
J Transl Med; 2021 Apr; 19(1):139. PubMed ID: 33794925
[TBL] [Abstract][Full Text] [Related]
20. The (Neutrophils + Monocyte)/Lymphocyte Ratio Is an Independent Prognostic Factor for Progression-Free Survival in Newly Diagnosed Multiple Myeloma Patients Treated With BCD Regimen.
Pang Y; Shao H; Yang Z; Fan L; Liu W; Shi J; Wang Y; Han Y; Yang L
Front Oncol; 2020; 10():1617. PubMed ID: 32984029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
